USD10
ORMP Shares
About Oramed PharmaceuticalsOramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
USD10
ORMP Shares
About Oramed PharmaceuticalsOramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Stats
TRADING WINDOW
Closed
OPENS AT
Jun 12 at 1:30 PM GMT+0
MARKET CAP
$158.38M
OPEN PRICE
$3.83
LOW (1Y)
$1.98
HIGH (1Y)
$5.01
LOW (24H)
$3.81
HIGH (24H)
$3.93
VOLUME (24H)
$112.83K
29.06%
Price history
Time | Price | Change |
|---|---|---|
Today | $3.83 | |
1 Day | $3.80 | |
1 Week | $3.71 | |
1 Month | $4.46 | |
1 Year | $2.12 |
Past performance is not a reliable indicator of future results.
Discover more
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.